20mg/ 30 tablets

Essential Steroid Aid For post Cycle Therapy

  • Helps prevent water retention
  • Aids in estrogen prodcution

Aromasin BY pur-pharm

Exemestane 20MG

Exemestane is being introduced under the brand name Aromasin among others. It is being treated as the best medicine for breast cancer. It comes from the class of antiestrogens which is called aromatase inhibitors.


Exemestane. . . . . . . . . . . . . . . . . . . . 20 mg

  • Chemical Name: 
    • The formula could be C20H24O2
    • Molar mass 295.403 g/mol








Arimidix, Clomid





*Note: Aromasin is not recommended for people being treated for prostate or testicular cancer or suffering from high blood pressure, stroke or liver damage.

Effective  protection during pct


From the research, we have seen that some breast cancers require estrogen to grow. These cancers have Estrogen receptors and formally we call them ER-positive. This medicine has a wide range of use.

It can be used as adjuvant treatment of postmenstrual women with estrogen receptor-positive with serious breast cancer. Exemestane is irreversible, steroidal aromatase inactivator for the case of type 1 which is related to the natural substrate 4-androstenedione.

Reasons For Delivery

From research, we have seen that a dose of 25 mg/day resulted in an almost 65% reduction in breast cancer compared with a placebo. In that case, the annual incidence rates were 0.19% and 0.55% respectively. This drug is widely used in doping to raise luteinizing hormone and follicle-stimulating hormone levels. This process will help to increase the ratio of male over female sexual hormones and so improve performance.

Benefits of Aromasin 20

It is an effective medicine for advanced breast cancer. At the same time, it can work well as adjuvant treatment for ovarian suppression and the aromatase inhibitor Exemestane. This awesome drug is contraindicated in premenopausal women and that will be helpful for pregnant and lactating women.
There are some side effects also but the quantity is really low it could be near around 10%. The premenopausal woman who is receiving ovarian suppression will be benefited from an aromatase inhibitor. It will also counteract effective gynecomastia.